HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paulo A Ferreira Selected Research

Retinitis Pigmentosa (Pigmentary Retinopathy)

2/2012Structural and functional plasticity of subcellular tethering, targeting and processing of RPGRIP1 by RPGR isoforms.
4/2011Evidence for RPGRIP1 gene as risk factor for primary open angle glaucoma.
11/2009RPGRIP1 is essential for normal rod photoreceptor outer segment elaboration and morphogenesis.
11/2007The cyclophilin-like domain of Ran-binding protein-2 modulates selectively the activity of the ubiquitin-proteasome system and protein biogenesis.
12/2005Interaction of nephrocystin-4 and RPGRIP1 is disrupted by nephronophthisis or Leber congenital amaurosis-associated mutations.
10/2005Insights into X-linked retinitis pigmentosa type 3, allied diseases and underlying pathomechanisms.
5/2005Limited proteolysis differentially modulates the stability and subcellular localization of domains of RPGRIP1 that are distinctly affected by mutations in Leber's congenital amaurosis.
8/2002Species-specific subcellular localization of RPGR and RPGRIP isoforms: implications for the phenotypic variability of congenital retinopathies among species.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paulo A Ferreira Research Topics

Disease

8Retinitis Pigmentosa (Pigmentary Retinopathy)
02/2012 - 08/2002
4Ganglion Cysts (Ganglion)
09/2019 - 09/2002
3Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
09/2019 - 02/2014
2Hypertrophy
09/2019 - 01/2017
2Osteogenesis Imperfecta (Lobstein Disease)
02/2014 - 06/2012
2Blindness (Hysterical Blindness)
04/2011 - 08/2002
2Glaucoma
04/2011 - 08/2009
1Respiratory Paralysis
01/2017
1Phototoxic Dermatitis (Phototoxicity)
12/2015
1Proteostasis Deficiencies
02/2014
1Brain Diseases (Brain Disorder)
06/2013
1Transverse Myelitis (Necrotizing Myelitis)
06/2013
1Neurodegenerative Diseases (Neurodegenerative Disease)
06/2013
1Neoplasms (Cancer)
06/2013
1Nervous System Diseases (Neurological Disorders)
10/2012
1Gliosis
10/2012
1Parkinson Disease (Parkinson's Disease)
10/2012
1Parkinsonian Disorders (Parkinsonism)
10/2012
1Pathologic Processes
06/2012
1Retinal Dystrophies
02/2012
1Low Tension Glaucoma
04/2011
1Open-Angle Glaucoma (Glaucoma, Open Angle)
04/2011
1Carcinogenesis
09/2010
1Fabry Disease (Fabry's Disease)
05/2007
1Retinal Diseases
05/2005

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
02/2014 - 05/2005
9ran-binding protein 2IBA
09/2019 - 09/2002
8GTP Phosphohydrolases (GTPases)IBA
02/2012 - 08/2002
4Retinaldehyde (Retinal)IBA
09/2019 - 05/2005
2cyclophilin BIBA
02/2014 - 06/2012
2Biological ProductsIBA
06/2012 - 05/2005
1Carisoprodol (Soma)FDA LinkGeneric
09/2019
1ChemokinesIBA
01/2017
1Nonesterified Fatty Acids (NEFA)IBA
01/2017
1Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA
02/2014
1Cyclophilins (Cyclophilin)IBA
02/2014
1OpsinsIBA
02/2014
1ChromatinIBA
10/2012
1NeurotoxinsIBA
10/2012
1Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
10/2012
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
10/2012
1ImmunophilinsIBA
06/2012
1NucleotidesIBA
02/2012
1Protein Isoforms (Isoforms)IBA
02/2012
1Biomarkers (Surrogate Marker)IBA
08/2009
1alpha-Galactosidase (Beano)IBA
05/2007
1GlycolipidsIBA
05/2007

Therapy/Procedure

1Enzyme Replacement Therapy
05/2007